Posted on February 24, 2008 in Latest News
Blepharitis refers to chronic inflammation of the eyelids and eyelashes causing red, irritated, itchy eyelids and the formation of dandruff-like scales on eyelashes. There are two types of blepharitis.
- Anterior blepharitis affects the front of the eyelids near the eyelashes. The causes are seborrheic dermatitis (similar to dandruff) and occasional infection by Staphylococcus bacteria.
- Posterior blepharitis affects the back of the eyelids, the part that makes contact with the eyes. This is caused by the oil glands present in this region. It is by far, the most common type of blepharitis.
Symptoms
Individuals with blepharitis may experience a gritty or burning sensation in their eyes, excessive tearing, itching, red and swollen eyelids, dry eyes, or crusting of the eyelids. For some people, blepharitis causes only minor irritation and itching. However, it can lead to more severe symptoms such as blurring of vision, missing or misdirected eyelashes, and inflammation of other eye tissue, particularly the cornea.
Causes
Anterior blepharitis is commonly caused by bacteria (staphyloccus blepharits) or dandruff of the scalp and eyebrows (seborrheic blepharitis). It may also occur due to a combination of factors, or less commonly may be the result of allergies or an infestation of lice on the eyelashes.
Posterior blepharitis can be caused by excessive oil production by the glands of the eyelids (meibomian blepharitis) which creates a favorable environment for bacterial growth. It can also develop as a result of other skin conditions such as acne rosacea and scalp dandruff.
Treatment
Treatment depends on the type of blepharitis you have. It may include applying warm compresses to the eyelids, cleansing them, using an antibiotic and/or massaging the lids. However, blepharitis rarely disappears completely. Even with successful treatment, relapses are common. Paying extra attention to good hygiene at those times may help bring the condition back under control.
» Filed Under Latest News
Comments
Leave a Reply
